Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Here we provide a literature database for flavonoids, focused upon quercetin, rutin, isorhamnetin, and their related compounds. Original papers and reviews about in vitro, in vivo, and clinical pharmacologies are contained here.

Search

Result:: 1-10 Hits of 25

Quercetin Promotes the M1-to-M2 Macrophage Phenotypic Switch During Liver Fibrosis Treatment by Modulating the JAK2/STAT3 Signaling Pathway

Authors:: Dongqi Sun; Xiaoling Zhou; Teng Wu; Zepeng Li; Shigao Huang; Zheng Peng

Reference:: Recent Patents on Anti-Cancer Drug Discovery; 2024; 19; in press

DOI:: 10.2174/0115748928318948240920044716

See Abstract

Quercetin alleviates liver fibrosis via regulating glycolysis of liver sinusoidal endothelial cells and neutrophil infiltration

Authors:: Xiaoying Chen; Yifan Wang; Jie Wan; Xiaoyun Dou; Chuzhao Zhang; Meng Sun; Fang Ye

Reference:: Biomolecules and Biomedicine; 2024; 24; 1806–1815

DOI:: 10.17305/bb.2024.10530

See Abstract

Investigating the Inhibitory Effect of Isorhamnetin on the Expression of NOXs Genes as well as the Level of ROS in Hepatic Stellate Cells and Its Role in Preventing the Progression of Liver Fibrogenesis

Authors:: Mojtaba Rashidi; Maryam Cheraghzadeh; Elham Shakerian; Emad Matour; Hasti Beheshti Nasab; Samaneh Salehipour Bavarsad

Reference:: Journal of Isfahan Medical School; 2024; 42; 113-120

DOI:: 10.48305/JIMS.V42.I757.0113

See Abstract

A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms

Authors:: Fei Xiong; Yichen Zhang; Ting Li; Yiping Tang; Si-Yuan Song; Qiao Zhou; Yi Wang

Reference:: Frontiers in Pharmacology; 2024; 15; 1389179

DOI:: 10.3389/fphar.2024.1389179

See Abstract

Quercetin ameliorates liver fibrosis in Wilson disease and EMT involving suppression of the Hedgehog signaling pathway

Authors:: Jie Chen; Wenming Yang; Ting Dong; Huaizhen Chen; Jing Zhang; Guocun Xu; Chenling Zhao; Jingyu Zeng; Lulu Tang

Reference:: Arabian Journal of Chemistry; 2024; 17; 105487

DOI:: 10.1016/j.arabjc.2023.105487

See Abstract

Isorhamnetin Exerts Antifibrotic Effects by Attenuating Platelet-Derived Growth Factor-BB-induced HSC-T6 Cells Activation via Suppressing PI3K-AKT Signaling Pathway

Authors:: Mojtaba Rashidi; Emad Matour; Hasti Beheshti Nasab; Maryam Cheraghzadeh; Elham Shakerian

Reference:: Iranian Biomedical Journal; 2023; 27; 199–204

DOI:: 10.52547/ibj.3948

See Abstract

Quercetin nanocrystals prepared by a novel technique improve dissolution rate and antifibrotic activity of quercetin

Authors:: Pegah Cheshmehnoor; Shahram Rabbani; Azadeh Haeri

Reference:: Nanomedicine; 2023; 18; 89–107

DOI:: 10.2217/nnm-2022-0032

See Abstract

Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis

Authors:: Meijie Jiang; Chunmei Huang; Qiong Wu; Yong Su; Xinming Wang; Zihua Xuan; Yunlai Wang; Fan Xu; Chaoliang Ge

Reference:: Journal of Ethnopharmacology; 2023; 303; 115965

DOI:: 10.1016/j.jep.2022.115965

See Abstract

The construction of preclinical evidence for the treatment of liver fibrosis with quercetin: A systematic review and meta-analysis

Authors:: Xiaochuan Guo; Yuanyuan Li; Weizheng Wang; Luyao Wang; Sihan Hu; Xiaolin Xiao; Caiyu Hu; Yao Dai; Yiheng Zhang; Ziyu Li; Junlin Li; Xiao Ma; Jinhao Zeng

Reference:: Phytotherapy Research; 2022; 36; 3774-3791

DOI:: 10.1002/ptr.7569

See Abstract

Quercetin ameliorates thioacetamide-induced hepatic fibrosis and oxidative stress by antagonizing the Hedgehog signaling pathway

Authors:: Andleeb Aslam; Nadeem Sheikh; Muhammad Shahzad; Ghazala Saeed; Naz Fatima; Tasleem Akhtar

Reference:: Journal of Cellular Biochemistry; 2022; 123; 1356-1365

DOI:: 10.1002/jcb.30296

See Abstract